Lifecore Biomedical Inc [LFCR] stock is trading at $7.60, up 8.11%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The LFCR shares have gain 1.74% over the last week, with a monthly amount glided 3.97%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Lifecore Biomedical Inc [NASDAQ: LFCR] stock has seen the most recent analyst activity on September 05, 2024, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $8. Previously, Barrington Research downgraded its rating to Mkt Perform on August 28, 2024. On March 20, 2023, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $2 on the stock.
Lifecore Biomedical Inc [LFCR] stock has fluctuated between $3.68 and $8.90 over the past year. Currently, Wall Street analysts expect the stock to reach $6.5 within the next 12 months. Lifecore Biomedical Inc [NASDAQ: LFCR] shares were valued at $7.60 at the most recent close of the market. An investor can expect a potential drop of -14.47% based on the average LFCR price forecast.
Analyzing the LFCR fundamentals
Lifecore Biomedical Inc [NASDAQ:LFCR] reported sales of 128.44M for the trailing twelve months, which represents a growth of 0.75%. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.17 and Total Capital is -0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-32.48.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.12 points at the first support level, and at 6.64 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.86, and for the 2nd resistance point, it is at 8.11.
Ratios To Look Out For
For context, Lifecore Biomedical Inc’s Current Ratio is 1.83. As well, the Quick Ratio is 0.80, while the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 2.18 and price to earnings (TTM) ratio is 127.52.
Transactions by insiders
Recent insider trading involved Morberg John D, Former officer, that happened on Nov 20 ’24 when 10000.0 shares were purchased. Former officer, Morberg John D completed a deal on Nov 11 ’24 to buy 30990.0 shares. Meanwhile, Former officer Morberg John D bought 40989.0 shares on Oct 31 ’24.
